Presenilin-1 is an unprimed glycogen synthase kinase-3β substrate

FEBS Letters

Volumn 580, Issue 17, 2006, Pages 4015-4020

  Twomey, Ciara ^a   McCarthy, Justin V ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Alzheimer's disease; Gamma secretase; Glycogen synthase kinase 3 ; Phosphorylation; Presenilin 1

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; PRESENILIN 1;

ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SUBSTITUTION REACTION; WILD TYPE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BINDING SITES; CELL LINE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; POINT MUTATION; PRESENILIN-1; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUBSTRATE SPECIFICITY;

EID: 33745853091     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.06.035     Document Type: Article

References (28)

1. Kirschenbaum F., Hsu S.C., Cordell B., and McCarthy J.V. Substitution of a glycogen synthase kinase-3beta phosphorylation site in presenilin 1 separates presenilin function from beta-catenin signalling. J. Biol. Chem. 276 (2001) 7366-7375
2. Kirschenbaum F., Hsu S.C., Cordell B., and McCarthy J.V. Glycogen synthase kinase-3beta regulates presenilin 1 C-terminal fragment levels. J. Biol. Chem. 276 (2001) 30701-30707
3. Frame S., Cohen P., and Biondi R.M. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell 7 (2001) 1321-1327
4. Cruts M., and Van Broeckhoven C. Presenilin mutations in Alzheimer's disease. Hum. Mutat. 11 (1998) 183-190
5. Selkoe D.J., and Wolfe M.S. In search of gamma-secretase: presenilin at the cutting edge. Proc. Natl. Acad. Sci. USA 97 (2000) 5690-5692
6. Fortini M.E. Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling. Nat. Rev. Mol. Cell Biol. 3 (2002) 673-684
7. Koo E.H., and Kopan R. Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration. Nat. Med. 10 Suppl. (2004) S26-S33
8. McCarthy J.V. Involvement of presenilins in cell-survival signalling pathways. Biochem. Soc. Trans. 33 (2005) 568-572
9. Takashima A., et al. Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc. Natl. Acad. Sci. USA 95 (1998) 9637-9641
10. Jope R.S., and Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29 (2004) 95-102
11. Grimes C.A., and Jope R.S. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 65 (2001) 391-426
12. Phiel C.J., Wilson C.A., Lee V.M., and Klein P.S. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423 (2003) 435-439
13. Frame S., and Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359 (2001) 1-16
14. Baki L., Shioi J., Wen P., Shao Z., Schwarzman A., Gama-Sosa M., Neve R., and Robakis N.K. PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. EMBO J. 23 (2004) 2586-2596
15. Woodgett J.R. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 9 (1990) 2431-2438
16. Hart M.J., de los Santos R., Albert I.N., Rubinfeld B., and Polakis P. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr. Biol. 8 (1998) 573-581
17. Rubinfeld B., Albert I., Porfiri E., Fiol C., Munemitsu S., and Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272 (1996) 1023-1026
18. Thinakaran G., et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17 (1996) 181-190
19. Walter J., Grunberg J., Schindzielorz A., and Haass C. Proteolytic fragments of the Alzheimer's disease associated presenilins-1 and -2 are phosphorylated in vivo by distinct cellular mechanisms. Biochemistry 37 (1998) 5961-5967
20. Walter J., et al. Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase C. Proc. Natl. Acad. Sci. USA 94 (1997) 5349-5354
21. Fluhrer R., Friedlein A., Haass C., and Walter J. Phosphorylation of presenilin 1 at the caspase recognition site regulates its proteolytic processing and the progression of apoptosis. J. Biol. Chem. 279 (2004) 1585-1593
22. Walter J., Schindzielorz A., Grunberg J., and Haass C. Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis. Proc. Natl. Acad. Sci. USA 96 (1999) 1391-1396
23. Hagen T., Di Daniel E., Culbert A.A., and Reith A.D. Expression and characterization of GSK-3 mutants and their effect on beta-catenin phosphorylation in intact cells. J. Biol. Chem. 277 (2002) 23330-23335
24. Herreman A., Serneels L., Annaert W., Collen D., Schoonjans L., and De Strooper B. Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. Nat. Cell Biol. 2 (2000) 461-462
25. Lau K.F., Howlett D.R., Kesavapany S., Standen C.L., Dingwall C., McLoughlin D.M., and Miller C.C. Cyclin-dependent kinase-5/p35 phosphorylates Presenilin 1 to regulate carboxy-terminal fragment stability. Mol. Cell. Neurosci. 20 (2002) 13-20
26. Serban G., Kouchi Z., Baki L., Georgakopoulos A., Litterst C.M., Shioi J., and Robakis N.K. Cadherins mediate both the association between PS1 and beta-catenin and the effects of PS1 on beta-catenin stability. J. Biol. Chem. 280 (2005) 36007-36012
27. Lau L.F., and Ahlijanian M.K. Role of cdk5 in the pathogenesis of Alzheimer's disease. Neurosignals 12 (2003) 209-214
28. Noble W., et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc. Natl. Acad. Sci. USA 102 (2005) 6990-6995